台湾首见变种M痘境外移入 疾管署吁有风险者快打满疫苗
尚無 AI 分析資料。
常見問題
- Q: What new Mpox development was announced in Taiwan?
- A: Taiwan announced its first detected case of the Mpox clade I Ib substrain, a new variant for the country, found in a person who had traveled to Thailand.
- Q: How many new Mpox cases were reported in May?
- A: Two new cases were reported in May: one domestic case and one imported case from Thailand.
- Q: What is the significance of this new imported case?
- A: It is the first time the clade I Ib virus strain has been identified in Taiwan since Mpox became a notifiable infectious disease in 2022; all previous cases were of the clade II strain.
- Q: What is the Taiwan CDC's primary recommendation?
- A: The CDC strongly advises all eligible individuals, especially those with high-risk behaviors, to complete the two-dose Mpox vaccination course as soon as possible.
- Q: How effective is the Mpox vaccine according to the article?
- A: A complete two-dose vaccination provides about 90% protection against the Mpox virus, while a single dose offers only 40% to 80% protection. The vaccine is effective against both clade I and clade II strains.